These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16932606)

  • 1. Amyotrophic lateral sclerosis and gene therapy.
    Miller TM; Smith RA; Cleveland DW
    Nat Clin Pract Neurol; 2006 Sep; 2(9):462-3. PubMed ID: 16932606
    [No Abstract]   [Full Text] [Related]  

  • 2. RNAi therapy: dominant disease gene gets silenced.
    Xu Z; Xia XG
    Gene Ther; 2005 Aug; 12(15):1159-60. PubMed ID: 15858609
    [No Abstract]   [Full Text] [Related]  

  • 3. Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis.
    Miller TM; Kaspar BK; Kops GJ; Yamanaka K; Christian LJ; Gage FH; Cleveland DW
    Ann Neurol; 2005 May; 57(5):773-6. PubMed ID: 15852369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gene therapy of ALS with RNA interference].
    Yokota T
    Rinsho Shinkeigaku; 2009 Nov; 49(11):821-3. PubMed ID: 20030220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentiviral and adeno-associated vector-based therapy for motor neuron disease through RNAi.
    Towne C; Aebischer P
    Methods Mol Biol; 2009; 555():87-108. PubMed ID: 19495690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has gene therapy for ALS arrived?
    Miller TM; Cleveland DW
    Nat Med; 2003 Oct; 9(10):1256-7. PubMed ID: 14520369
    [No Abstract]   [Full Text] [Related]  

  • 7. AAV6-mediated gene silencing fALS short.
    Mandel RJ; Lowenstein PR; Byrne BJ
    Mol Ther; 2011 Feb; 19(2):231-3. PubMed ID: 21289637
    [No Abstract]   [Full Text] [Related]  

  • 8. [Gene therapy of ALS with short interfering RNA].
    Yokota T
    Brain Nerve; 2007 Oct; 59(10):1187-94. PubMed ID: 17969360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental therapies hold promise for treating amyotrophic lateral sclerosis.
    Friedrich MJ
    JAMA; 2005 Mar; 293(9):1048-9. PubMed ID: 15741517
    [No Abstract]   [Full Text] [Related]  

  • 10. RNA interference protects against ALS in mouse model.
    Burton A
    Lancet Neurol; 2005 May; 4(5):274-5. PubMed ID: 15861555
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene Therapy for ALS: progress and prospects.
    Azzouz M
    Biochim Biophys Acta; 2006; 1762(11-12):1122-7. PubMed ID: 16806843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis.
    Ding H; Schwarz DS; Keene A; Affar el B; Fenton L; Xia X; Shi Y; Zamore PD; Xu Z
    Aging Cell; 2003 Aug; 2(4):209-17. PubMed ID: 12934714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of disease duration of amyotrophic lateral sclerosis in a mouse model by transgenic small interfering RNA.
    Yokota T; Sasaguri H; Saito Y; Yamada H; Unno T; Yamamoto Y; Kubodera T; Anzai M; Mitani T; Mizusawa H
    Arch Neurol; 2007 Jan; 64(1):145-6. PubMed ID: 17210827
    [No Abstract]   [Full Text] [Related]  

  • 14. An RNAi strategy for treatment of amyotrophic lateral sclerosis caused by mutant Cu,Zn superoxide dismutase.
    Xia XG; Zhou H; Zhou S; Yu Y; Wu R; Xu Z
    J Neurochem; 2005 Jan; 92(2):362-7. PubMed ID: 15663483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis.
    Nizzardo M; Simone C; Falcone M; Riboldi G; Rizzo F; Magri F; Bresolin N; Comi GP; Corti S
    Cell Mol Life Sci; 2012 May; 69(10):1641-50. PubMed ID: 22094924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finding a Treatment for ALS - Will Gene Editing Cut It?
    Al-Chalabi A; Brown RH
    N Engl J Med; 2018 Apr; 378(15):1454-1456. PubMed ID: 29641956
    [No Abstract]   [Full Text] [Related]  

  • 17. Oligonucleotide therapies: the future of amyotrophic lateral sclerosis treatment?
    Aoki Y; Douglas AG; Wood MJ
    Neurodegener Dis Manag; 2015; 5(2):93-5. PubMed ID: 25894871
    [No Abstract]   [Full Text] [Related]  

  • 18. siRNAs meet their match.
    Potash J
    Nat Methods; 2006 Nov; 3(11):876. PubMed ID: 17124734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.
    Raoul C; Abbas-Terki T; Bensadoun JC; Guillot S; Haase G; Szulc J; Henderson CE; Aebischer P
    Nat Med; 2005 Apr; 11(4):423-8. PubMed ID: 15768028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model.
    Ralph GS; Radcliffe PA; Day DM; Carthy JM; Leroux MA; Lee DC; Wong LF; Bilsland LG; Greensmith L; Kingsman SM; Mitrophanous KA; Mazarakis ND; Azzouz M
    Nat Med; 2005 Apr; 11(4):429-33. PubMed ID: 15768029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.